MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

503908

Report Date :

17.04.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

B.BRAUN MEDICAL (INDIA) PRIVATE LIMITED

 

 

Registered Office :

Unit No.601, Wing A, 6th Floor, Boomerang, Chandivali Farm Road, Near Chandivali Studio, Mumbai – 400072, Maharashtra

Tel. No.:

91-22-66682222

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

28.03.1984

 

 

Com. Reg. No.:

11-214514

 

 

Capital Investment / Paid-up Capital :

INR 590.908 Million

 

 

CIN No.:

[Company Identification No.]

U33112MH1984PTC214514

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAACB7394M

 

 

GSTN :

[Goods & Service Tax Registration No.]

27AAACB7394M1Z5

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

  • The Company trades in the field of Healthcare, catering to therapeutic segments such as Anesthesia, Surgery, Interventional Cardiology, Orthopedics, Dialysis Treatment and Hospital Care.

 

  • The company manufactures Sutures using latest technology.

 

(Registered Activity)

 

 

No. of Employees :

Information declined by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1984. It is a subsidiary of B. Braun Medical Industries Sdn Bhd, Malaysia.

 

As per the financial of 2017, the company has achieved a fair growth in its revenue as compared to the previous year’s revenue and has gained an average net profit margin of 4.28%.

 

The sound financial position of the company is marked by healthy networth base along with adequate debt protection metrics.

 

These strengths are partially offset by working capital-intensive operations, and exposure to risks related to intense competition and to volatility in foreign exchange rates.

 

Business is active. Payment seems to be regular.

 

In view of aforesaid, the company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Loans=A-

Rating Explanation

Adequate degree of safety and low credit risk.

Date

30.06.2017

 

Rating Agency Name

CRISIL

Rating

Short Term Loans=A2+

Rating Explanation

Strong degree of safety and low credit risk.

Date

30.06.2017

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2018.

 

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 17.04.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

 

 

INFORMATION DENIED

 

MANAGEMENT NON-COOPERATIVE (Tel. No.: 91-22-66682222)

 

 

LOCATIONS

 

Registered Office :

Unit No.601, Wing A, 6th Floor, Boomerang, Chandivali Farm Road, Near Chandivali Studio, Mumbai – 400072, Maharashtra, India

Tel. No.:

91-22-66682222

Fax No.:

Not Available

E-Mail :

legal.in@bbraun.com

info.in@bbraun.com

Website :

www.bbraun.com

 

 

Plant :

Located at:

 

  • Chennai

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Indranil Mukherjee

Designation :

Managing Director

Address :

A-204, Sahayog Housing Complex, Tikujini Wadi Road, Thane (West), Thane – 400610, Maharashtra, India

Date of Appointment :

08.08.2017

DIN No.:

06692898

 

 

Name :

Ms. Minakshi Subhash Samant

Designation :

Director

Address :

A-1403, Green Park CHS, Raheja Estate Borivali (East), Mumbai – 400066, Maharashtra, India

Date of Appointment :

08.08.2017

DIN No.:

07138138

 

 

Name :

Mr. Andreas Walde

Designation :

Director

Address :

521D-33A-01, The Cove, Jalan TG. Bungah Tanjung Bunga, Penang 11200 MY

Date of Birth/Age :

07.06.1970

Date of Appointment :

05.11.2015

DIN No.:

07331893

 

 

Name :

Christoph Mueller

Designation :

Additional Director

Address :

Marriott Executive Apartment - Lakeside Chalet, 2 and 3B, Near Chinmayanand Ashram, Powai, Mumbai – 400087, Maharashtra, India

Date of Appointment :

23.11.2017

DIN No.:

08000451

 

KEY EXECUTIVES

 

Name :

Mr. Tauseef Nuruddin Shaikh

Designation :

Company Secretary

Address :

305/3rd Floor, Ganesh Krupa Building, Near Parsik Tunnel, Mumbai – 400612, Maharashtra, India

Date of Appointment :

01.09.2017

PAN No.:

BOLPS7887H

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2017

 

Names of Shareholders

 

No. of Shares

B. Braun Medical Industries Sdn Bhd, Malaysia

 

5909081

B Braun Medical International, Spain

 

1

Total

 

5909082

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2017

 

Category

Percentage

Promoters (Others-Foreign Body Corporates)

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

  • The Company trades in the field of Healthcare, catering to therapeutic segments such as Anesthesia, Surgery, Interventional Cardiology, Orthopedics, Dialysis Treatment and Hospital Care.

 

  • The company manufactures Sutures using latest technology.

 

(Registered Activity)

 

 

Products/ Services :

Item Code No.

Product/ Services Description

98041000

Drugs and Medicines

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

Bank Name

Not Divulged

Branch

Not Divulged

Person Name (With Designation)

--

Contact Number

--

Name of Account Holder

--

Account Number

--

Account Since (Date/Year of Account Opening)

--

Average Balance Maintained (If Possible)

--

Credit Facilities Enjoyed (If any)

--

Account Operation

--

Remarks (If any)

--

 

 

 

Auditors :

 

Name :

Price Waterhouse and Company Bangalore LLP

Chartered Accountants

Address :

Nesco IT Building III, 8th Floor, Nesco IT Park, Nesco Complex, Gate No. 3, Western Express Highway, Goregaon (East), Mumbai – 400063, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AADFP9359C

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Holding Company :

B. Braun Medical Industries Sdn. Bhd., Malaysia

 

 

Ultimate Holding Company :

B. Braun Melsungen AG, Germany

 

 

Subsidiary company

Oyster Medisafe Private Limited

 

 

Fellow Subsidiary

Companies :

  • Aesculap AG and Co KG.
  • B. Braun Medical S.A. , France
  • B. Braun Surgical S.A. , Spain
  • Suturex and Renodex SAS
  • B. Braun Avitum AG
  • B. Braun Medical Inc. USA
  • Aesculap Fleximed GmbH
  • Ahlcon Parenterals (India) Limited
  • B. Braun Korea Company Limited
  • B. Braun Medical S.A. , Colombia
  • B. Braun Medical Supplies Inc.
  • B. Braun Medical Supplies Sdn. Bhd.
  • B. Braun Avitum Philippines Inc.
  • B. Braun Medical SAS
  • B. Braun Pakistan (Private) Limited
  • B. Braun Vietnam Company Limited
  • B. Braun (Thailand) Limited
  • B. Braun Lanka (Pvt) Limited
  • B. Braun Singapore Pte. Limited
  • Aesculap Akademie Gmbh
  • B. Braun Medical (H.K.) Limited
  • PT B. Braun Medical Indonesia
  • B. Braun Medical Inc.
  • ACC Beruhazo Kft.
  • B. Braun Avitum Italy S.p.A.
  • B. Braun Australia Pty. Limited
  • B. Braun Medical Oy
  • B. Braun Medical AG
  • B. Braun Medical Kft.
  • B. Braun Austria GmbH
  • B. Braun Austria GmbH

 

 

CAPITAL STRUCTURE

 

As on 30.09.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5910000

Equity Shares

INR 100/- each

INR 591.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5909082

Equity Shares

INR 100/- each

INR 590.908 Million

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

590.908

590.908

590.908

(b) Reserves and Surplus

1077.649

868.656

646.787

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1668.557

1459.564

1237.695

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long-term liabilities

0.000

0.000

0.000

(d) long-term provisions

18.455

16.097

14.364

Total Non-current Liabilities (3)

18.455

16.097

14.364

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

506.733

549.144

592.046

(b) Trade payables

570.492

551.763

638.847

(c) Other current liabilities

156.648

177.473

299.714

(d) Short-term provisions

100.187

112.290

118.668

Total Current Liabilities (4)

1334.060

1390.670

1649.275

 

 

 

 

TOTAL

3021.072

2866.331

2901.334

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

192.169

235.524

297.664

(ii) Intangible Assets

0.096

0.187

0.687

(iii) Tangible assets capital work-in-progress

28.166

11.997

9.956

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

526.412

526.412

376.412

(c) Deferred tax assets (net)

106.701

87.530

81.843

(d) Long-term loans and advances

57.483

58.504

58.077

(e) Other Non-current assets

13.303

9.405

3.680

Total Non-Current Assets

924.330

929.559

828.319

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

878.999

943.856

1127.363

(c) Trade receivables

754.514

728.365

691.158

(d) Cash and bank balances

64.967

20.421

18.476

(e) Short-term loans and advances

138.389

171.721

180.300

(f) Other current assets

259.873

72.409

55.718

Total Current Assets

2096.742

1936.772

2073.015

 

 

 

 

TOTAL

3021.072

2866.331

2901.334

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Total Revenue from operations

4878.247

4291.723

4833.208

 

Other Income

50.409

8.554

6.264

 

TOTAL

4928.656

4300.277

4839.472

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

842.901

692.829

857.669

 

Purchases of Stock-in-Trade

2280.144

1754.189

2680.757

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

28.958

233.961

(189.053)

 

Employee benefit expense

430.243

383.263

378.197

 

CSR expenditure

1.176

0.000

0.000

 

Other expenses

892.903

770.419

778.454

 

TOTAL

4476.325

3834.661

4506.024

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

452.331

465.616

333.448

 

 

 

 

 

Less

FINANCIAL EXPENSES

53.858

80.577

74.066

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

398.473

385.039

259.382

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

74.151

87.642

83.088

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

324.322

297.397

176.294

 

 

 

 

 

Less

TAX

115.329

75.528

81.827

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

208.993

221.869

94.467

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

1241.461 

1146.798

1338.312 

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

35.37

37.55

15.99

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

340.118

398.228

198.336

Net cash flow from operating activity

185.383

298.301

149.648

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

56.45

61.95

52.20

 

 

 

 

Account Receivables Turnover

( Income / Sundry Debtors)

6.47

5.89

6.99

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

66.68

82.30

65.90

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.51

0.49

0.30

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

2.05

1.88

1.08

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.44

0.49

0.57

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.30

0.38

0.48

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.80

0.95

1.33

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.13

0.17

0.25

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

8.40

5.78

4.50

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

[(PAT / Sales) * 100]

%

4.28

5.17

1.95

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

6.92

7.74

3.26

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

12.53

15.20

7.63

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.57

1.39

1.26

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.91

0.71

0.57

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.55

0.51

0.43

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.86

0.93

1.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.57

1.39

1.26

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Share Capital

590.908

590.908

590.908

Reserves & Surplus

646.787

868.656

1077.649

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

1237.695

1459.564

1668.557

 

 

 

 

Long-term borrowings

0.000

0.000

0.000

Short term borrowings

592.046

549.144

506.733

Total borrowings

592.046

549.144

506.733

Debt/Equity ratio

0.478

0.376

0.304

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

4833.208

4291.723

4878.247

 

 

(11.203)

13.666

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR In Million)

(INR In Million)

(INR In Million)

Sales

4833.208

4291.723

4878.247

Profit/ (Loss)

94.467

221.869

208.993

 

1.95 %

5.17 %

4.28 %

 

 

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

590.908

590.908

(b) Reserves and Surplus

 

754.032

659.654

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

1344.940

1250.562

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

0.000

0.000

(d) long-term provisions

 

21.269

19.689

Total Non-current Liabilities (3)

 

21.269

19.689

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

1135.679

1054.441

(b) Trade payables

 

642.163

566.294

(c) Other current liabilities

 

199.790

243.571

(d) Short-term provisions

 

100.131

112.286

Total Current Liabilities (4)

 

2077.763

1976.592

 

 

 

 

TOTAL

 

3443.972

3246.843

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

499.481

470.945

(ii) Intangible Assets

 

6.505

9.029

(iii) Tangible assets capital work-in-progress

 

77.436

58.417

(iv) Intangible assets under development

 

402.329

402.329

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

106.701

87.530

(d) Long-term loans and advances

 

127.469

147.693

(e) Other Non-current assets

 

13.675

9.777

Total Non-Current Assets

 

1233.596

1185.720

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

1039.114

1042.781

(c) Trade receivables

 

802.699

748.544

(d) Cash and bank balances

 

65.684

20.710

(e) Short-term loans and advances

 

150.177

176.389

(f) Other current assets

 

152.702

72.699

Total Current Assets

 

2210.376

2061.123

 

 

 

 

TOTAL

 

3443.972

3246.843

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Total Revenue from operations

 

5198.544

4498.401

 

Other Income

 

51.225

8.947

 

TOTAL

 

5249.769

4507.348

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1075.414

857.259

 

Purchases of Stock-in-Trade

 

2264.367

1718.171

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(23.763)

189.112

 

Employee benefit expense

 

465.568

411.258

 

CSR expenditure

 

1.176

0.000

 

Other expenses

 

1026.047

886.358

 

TOTAL

 

4808.809

4062.158

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

440.960

445.190

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

116.717

131.727

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

324.243

313.463

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

114.536

119.580

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

209.707

193.883

 

 

 

 

 

Less

TAX

 

115.329

75.528

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

 

94.378

118.355

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

15.97

20.03

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

No

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

 

 

 

STATE OF COMPANY’S AFFAIRS AND FUTURE OUTLOOK

 

During the year, turnover of the Company, on standalone basis, has increased by INR 628.600 Million from total INR 4300.000 Million in the previous year to INR 4928.600 Million approximately there by recording growth of 14.61%.

 

Profit before tax is INR 324.300 Million compared to INR 297.300 Million in previous year on standalone basis and Profit after tax is INR 208.900 Million compared to INR 221.800 Million in previous year on standalone basis.

 

 

UNSECURED LOAN

 

PARTICULARS

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Short-term borrowings

 

 

Rupee term loans from banks

506.733

549.144

 

 

 

Total

506.733

549.144

 

 

INDEX OF CHARGES

 

Charges Registered

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Satisfaction

Amount

Address

1

A03576030

90076178

DEUTSCHE BANK

18/09/1996

09/08/2006

40000000.0

BOMBAY BRANCH POST BOX NO 11 42 HAZARIMAL SOMANI MARG FORT MUMBAI MAHARASHTRA 400001 INDIA

 

 

FIXED ASSETS

 

  • Land
  • Buildings
  • Factory building
  • Plant and equipment
  • Other plant and equipment
  • Furniture and fixtures
  • Vehicles
  • Motor vehicles
  • Office equipment
  • Computer equipments

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.44

UK Pound

1

INR 93.27

Euro

1

INR 80.73

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUP

 

 

Analysis Done by :

NYT

 

 

Report Prepared by :

SUD

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

 

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.